Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group

Assessment of minimal residual disease has emerged as a powerful prognostic factor in acute myeloid leukemia. In this study, we investigated the potential of IDH1/2 mutations as targets for minimal residual disease assessment in acute myeloid leukemia, since these mutations collectively occur in 15–...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Haematologica
Autori principali: Ferret, Yann, Boissel, Nicolas, Helevaut, Nathalie, Madic, Jordan, Nibourel, Olivier, Marceau-Renaut, Alice, Bucci, Maxime, Geffroy, Sandrine, Celli-Lebras, Karine, Castaigne, Sylvie, Thomas, Xavier, Terré, Christine, Dombret, Hervé, Preudhomme, Claude, Renneville, Aline
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ferrata Storti Foundation 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927984/
https://ncbi.nlm.nih.gov/pubmed/29472349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.183525
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi